NoteAntitumour imidazotetrazines: VII. Quantitative analysis of mitozolomide in biological fluids by high-performance liquid chromatography
References (10)
Prog. Med. Chem.
(1976)- et al.
J. Med. Chem.
(1984) - et al.
Chem. Soc. Rev.
(1978) - et al.
J. Chem. Soc., Perkin Trans. 1
(1982) - et al.
Proc. 13th Int. Cancer Congr.
(September 8—15, 1982)
There are more references available in the full text version of this article.
Cited by (17)
Separation methods for alkylating antineoplastic compounds
2001, Journal of Chromatography B: Biomedical Sciences and ApplicationsTemozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials
1997, Cancer Treatment ReviewsDetermination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction
1995, Journal of Chromatography B: Biomedical Sciences and ApplicationsPhase I trial of temozolomide using an extended continuous oral schedule
1998, Cancer ResearchAntitumour imidazotetrazines. Part 31. The synthesis of isotopically labelled temozolomide and a multinuclear (<sup>1</sup>H,<sup>13</sup>C,<sup>15</sup>N) magnetic resonance investigation of temozolomide and mitozolomide
1995, Journal of the Chemical Society, Perkin Transactions 1
Copyright © 1985 Published by Elsevier B.V.